Nada Yoga Music Therapy for Pain and Anxiety in Labor (NCT07392112) | Clinical Trial Compass
CompletedNot Applicable
Nada Yoga Music Therapy for Pain and Anxiety in Labor
Turkey (Türkiye)52 participantsStarted 2025-05-01
Plain-language summary
This study was designed as a randomized controlled trial. Based on the power analysis (Cohen's d = 0.80, α = 0.05, power = 80%), a total of 52 pregnant women were included, with 26 participants in the intervention group and 26 in the control group. Pregnant women who met the inclusion criteria and provided written informed consent were randomly assigned to the groups using a computer-generated randomization method.
The intervention group received Nada Yoga music therapy after admission to the delivery room, and the intervention was continued until birth. The therapy consisted of music compatible with the philosophy of Nada Yoga, including relaxing melodies, mantras, and nature sounds, which were delivered via speakers placed in the labor room. The control group received standard obstetric care.
Data were collected using the Pregnant Woman Information Form, Labor Follow-up Form, Visual Analog Scale (VAS), and the Spielberger State Anxiety Inventory.
Who can participate
Age range
18 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Having no impairment in communication skills
* Voluntarily agreeing to participate in the study
* Being between 37-42 weeks of gestation
* Planning a vaginal delivery
* Having no high-risk factors during pregnancy
* Having a singleton pregnancy
* Having a vertex fetal presentation
Exclusion Criteria:
* Individuals with communication problems
* Those who do not volunteer to participate in the study
* Pregnant women before 37 weeks of gestation or after 42 weeks of gestation
* Pregnant women with a planned cesarean delivery
* Pregnant women with gestational diabetes, preeclampsia, or other obstetric risk factors
* Those with multiple pregnancies
* Those with non-vertex fetal presentations (e.g., breech, transverse)
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Primary Outcome Measure
Timeframe: Before the intervention (when cervical dilatation reached 4-5 cm) and after the intervention during the active (4-7 cm) and transition (8-10 cm) phases of labor